Ledger.Open graph →
SEC Form D · Amendment · filed March 21, 2024

Gliknik Inc

Offering
$16.2M
Sold
$9.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Mark D. Lerner · Baltimore, MDDirectorScott E. Strome · Baltimore, MDDirectorKyle S. Rusconi · Baltimore, MDDirectorPaul A. Friedman · Baltimore, MDDirectorDavid S. Block · Baltimore, MDExec · DirectorRichard S. Levy · Baltimore, MDDirectorElizabeth C. Block · Baltimore, MDExecRaymond S. Schinazi · Baltimore, MDDirectorCharles S. Polsky · Baltimore, MDDirectorDavid C. Broser · Baltimore, MDDirectorCesar Cordero Kruger · Guaynabo, Puerto RicoDirectorScott E. Strome · Baltimore, MDDirectorGreg Vogel · Scottsdale, AZDirectorWilliam Gibbs · Calgary, Alberta, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗